Chlorambucil-Bearing Hybrid Molecules in the Development of Potential Anticancer Agents
Molecules · 2023
DOI: 10.3390/molecules28196889 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Molecules, 2023. Verfasst von Sijongesonke Peter und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemistry, University of Fort Hare, Alice 5700, South Africa. Hauptthemen laut MEDLINE: Antineoplastic Agents, Breast Neoplasms. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 64 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: South African Medical Research Council, University of Fort Hare, National Research Foundation.
Abstract (Originalsprache)
Increasing cases of cancer have been a primary concern in recent decades. Developing new chemotherapeutics is challenging and has been faced with limitations, such as multidrug resistance, poor specificity, selectivity, and toxicity. The aforementioned factors contribute to treatment failure. Hybrid compounds have features that can overcome the limitations mentioned above. Chlorambucil, an anticancer drug that is used to treat prostate and breast cancer, suffers from poor aqueous solubility and specificity, a short half-life, and severe side effects, including anaemia and bone marrow suppression. It compromises the immune system, resulting in treatment failure. Hence, its combination with other pharmacophores has been reported to result in effective anticancer agents with fewer side effects and high therapeutic outcomes. Furthermore, this review gives an update (2010 to date) on the developments of chlorambucil hybrid compounds with anticancer activity, and the structure-activity relationship (SAR), and also highlights future strategies for developing novel anticancer agents.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Chemistry, University of Fort Hare, Alice 5700, South Africa.
ORCID-Profile: Sijongesonke Peter, Blessing Atim Aderibigbe
Förderung
- South African Medical Research Council
- University of Fort Hare
- National Research Foundation
Zitieren
APA
Peter, S., & Aderibigbe, B. A. (2023). Chlorambucil-Bearing Hybrid Molecules in the Development of Potential Anticancer Agents. Molecules. https://doi.org/10.3390/molecules28196889
Vancouver
Peter S, Aderibigbe BA. Chlorambucil-Bearing Hybrid Molecules in the Development of Potential Anticancer Agents. Molecules. 2023. doi:10.3390/molecules28196889
BibTeX
@article{Peter2023,
author = {Peter, Sijongesonke and Aderibigbe, Blessing Atim},
title = {Chlorambucil-Bearing Hybrid Molecules in the Development of Potential Anticancer Agents},
journal = {Molecules},
year = {2023},
doi = {10.3390/molecules28196889}
}
EUVIMED